Systemic Lupus Erythematosus (SLE) with CNS Involvement
This patient's presentation is highly consistent with systemic lupus erythematosus (SLE) with central nervous system involvement, and she requires immediate rheumatologic consultation, high-dose corticosteroids, and likely additional immunosuppression to prevent permanent neurological damage and reduce mortality risk.
Clinical Reasoning for SLE Diagnosis
This 41-year-old woman presents with a constellation of symptoms that form a classic pattern for SLE:
- Multisystem involvement: Chronic fatigue, recurrent infections (immune dysregulation), digestive issues, rosacea-like skin changes, and hair loss all point to systemic autoimmune disease 1
- Neuropsychiatric manifestations: The six-month progression of migraines, brain fog, and memory loss followed by acute seizures and aseptic meningitis is pathognomonic for neuropsychiatric SLE (NPSLE) 2
- Photosensitive migraine with flu-like symptoms: This acute flare pattern with photosensitivity, joint stiffness, and constitutional symptoms strongly suggests lupus flare 3, 2
- Aseptic meningitis: CSF showing meningitis without bacterial or viral etiology is a hallmark of CNS lupus 1
- Postpartum timing: The 2-year postpartum period is relevant as pregnancy can trigger or unmask autoimmune diseases, and the history of PPD may reflect early inflammatory changes 1
Immediate Diagnostic Workup Required
Serologic testing (order stat):
- ANA (antinuclear antibody) with reflex to anti-dsDNA and anti-Smith antibodies
- Complete complement levels (C3, C4, CH50) - typically low in active SLE 1
- Complete blood count with differential (looking for cytopenias)
- Comprehensive metabolic panel including renal function
- Urinalysis with microscopy (for proteinuria and cellular casts)
- ESR and CRP (inflammatory markers) 1
Additional CNS evaluation:
- MRI brain with and without contrast (looking for white matter lesions, vasculitis)
- Repeat lumbar puncture if initial CSF was not sent for: oligoclonal bands, IgG index, and autoantibodies in CSF
- EEG to characterize seizure activity
Thyroid function: Complete thyroid panel to rule out autoimmune thyroiditis, which commonly coexists with SLE 1
Immediate Treatment Protocol
Acute management for NPSLE with seizures:
High-dose corticosteroids: Initiate methylprednisolone 1000 mg IV daily for 3-5 days, followed by oral prednisone 1 mg/kg/day (typically 60-80 mg daily) 1
Seizure control: Start antiepileptic medication (levetiracetam 500-1000 mg twice daily is preferred as it has fewer drug interactions and no need for monitoring) 4
Immunosuppression: Based on severity of CNS involvement, add cyclophosphamide IV monthly or mycophenolate mofetil 1000-1500 mg twice daily after rheumatology consultation 1
Hydroxychloroquine: Start 200-400 mg daily (5 mg/kg/day) as foundational therapy for all SLE patients 1
Migraine Management During Acute Phase
For acute migraine attacks (while managing underlying SLE):
- Acetaminophen 1000 mg as first-line 5, 6
- NSAIDs should be used cautiously given potential renal involvement in SLE, but ibuprofen can be considered if renal function is normal 5, 6
- Avoid triptans initially until CNS vasculitis is ruled out, as they cause vasoconstriction 5, 6
For migraine prevention (once SLE is controlled):
- Candesartan 16 mg daily is first-line for migraine prevention and does not interfere with immunosuppression 4
- Propranolol is an alternative if candesartan is contraindicated 4, 5
- Avoid topiramate as it can worsen cognitive symptoms already present from NPSLE 4, 6
Critical Pitfalls to Avoid
Do not dismiss this as postpartum depression relapse: While PPD history is present, the acute neurological deterioration with seizures and aseptic meningitis demands immediate autoimmune workup 1
Do not attribute brain fog solely to chronic fatigue syndrome: Although brain fog occurs in 54% of patients with GI disorders and is associated with migraines, the acute progression with seizures indicates serious CNS pathology requiring urgent intervention 7, 3, 2
Do not delay immunosuppression: NPSLE with seizures carries significant morbidity and mortality risk; early aggressive treatment improves outcomes and prevents irreversible neurological damage 1
Do not overlook the skin manifestations: "Rosacea-like" rashes in a woman with multisystem symptoms should trigger consideration of malar rash or discoid lupus, not just rosacea 8
Monitoring and Follow-up
- Weekly monitoring during induction therapy: CBC, CMP, ESR/CRP, complement levels
- Ophthalmology referral within 6 months for hydroxychloroquine retinal toxicity screening 1
- Neurology follow-up for seizure management and EEG monitoring
- Rheumatology should manage long-term immunosuppression with goal of tapering steroids to lowest effective dose within 3-6 months 1
Prognosis and Long-term Management
With prompt diagnosis and aggressive treatment, most patients with NPSLE achieve remission, though some neurological symptoms may persist 1. The combination of high-dose corticosteroids and immunosuppression significantly reduces mortality and prevents progression to irreversible CNS damage 1. Long-term hydroxychloroquine reduces flare frequency and improves survival in SLE 1.